Menu
Search
Home
About Us
Board of Directors
Executive Team
Our History
Our Roots
Business Ethics & Compliance
Global Code of Conduct
Transparency in healthcare
Reporting concerns
Sustainability
Careers
The recruiting process
Our stories
Job Positions
Careers in Oncology
Consumer Healthcare
Analgesics
Cough, Cold & Allergy
Gastrointestinals
Lifestyle OTCs
Vitamins, Minerals & Supplements
Contact Us
The Menarini Group
Main Areas
Careers in Menarini
Pharmacovigilance
Report a concern related to a code of conduct violation
Report issues with Menarini’s Website or Apps
Media Contact
Out-Licensing
Countries
Covid-19
Monoclonal Antibodies
Data Privacy
Privacy Policy on the use of website
Cookie Policy
Netiquette of Menarini Group
Privacy Notice for social network users of Menarini Group
Privacy notices of Group Companies without a website
DPO contact details of Group Companies without a website
Privacy Notice to providers and suppliers
Pharmacovigilance privacy information notice
Privacy Information Notice for Job Applicants
Dermatology and Aesthetic Medicine
Diagnostics
Professional Diagnostics
Advanced Diagnostics
Prenatal testing
Primary and Secondary care
Innovation & Research
Our Pipeline and Products
Infectious diseases
Clinical Trials
Clinical trials database
Oncology
Harmony Project
Building Excellence Together
Manufacturing
Menarini Group’s health, safety and environmental policy
Pharmaceuticals
Anti-infectives
The Global Challenge of Antimicrobial resistance (AMR)
The impact of AMR
Carbapenem Resistant Enterobacterales
Cardiometabolic
Cardiology
Chronic Stable Angina
Heart Failure
Hypertension
Myocardial Infarction
Diabetes
Gout
Gastrointestinal Disorders
Pain
Respiratory & Allergology
Respiratory
Asthma
Chronic obstructive pulmonary disease (COPD)
Allergology
Allergic rhinitis
Urticaria
Men's Health
News
News Archive
Menarini Pills of Art
Minuti Menarini
The series of Menarini art volumes
Fair Play Menarini
Archive
Fair Play Menarini, International Awards 2021
Fair Play Menarini, International Awards 2020
Fair Play Menarini International Awards 2019
Fair Play Menarini International Awards 2018
Fair Play Menarini International Awards 2017
Fair Play Menarini International Awards 2016
Fair Play Menarini, International Awards 2023
Menarini and Farmindustria
EFPIA - We won’t rest campaign
Newsletter Subscribe
Congresses
Congresses Archive
Oncology
Hematologic Malignancies
Blastic plasmacytoid dendritic cell neoplasm (BPDCN)
By marking #BPDCNday, Menarini Group is giving a rare and aggressive blood cancer nowhere to hide
Relapsed/Refractory CD123 Expressing Hematologic Malignancies
Acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS)
Chronic Myelomonocytic Laukemia (CMML) and Myelofibrosis (MF)
Multiple Myeloma
Solid Tumors
Breast Cancer
Colorectal Cancers
Glioblastoma
Our Values
Partnering
Company Acquisitions
Collaboration with strategic partners
Other Innovative Partnerships
Our Recent agreements
Our Therapeutic focus areas
Quality comes first
Responsibility
Standing with children and young people, for their future
Our core mission: promoting health from every angle
Fighting for the Environment, a precious asset
The COVID Emergency
Terms and conditions